Glaucoma is a chronic eye condition that damages the optic nerve, often due to elevated intraocular pressure. Because vision loss occurs slowly and without early symptoms, early detection is essential to protect long-term sight.
At The Medical Group of New Jersey, our ophthalmology team provides comprehensive evaluation, individualized treatment plans, and lifelong monitoring to prevent or delay vision loss from glaucoma.
Most individuals with glaucoma do not notice symptoms until the disease is advanced. When symptoms do occur, they may include:
During your initial glaucoma evaluation at The Medical Group of New Jersey, your ophthalmologist will:
If you have risk factors, such as diabetes, African or Caribbean ancestry, steroid use, or family history, we incorporate these into your individualized monitoring plan.
A glaucoma diagnosis relies on identifying structural changes to the optic nerve and functional changes to vision. Testing generally includes:
Risk Assessment
You may be considered higher-risk if you have:
Your ophthalmologist will determine your “target eye pressure” and design a personalized plan to reach and maintain that level.
Glaucoma treatment focuses on lowering eye pressure to protect the optic nerve. Treatment plans are individualized and may include:
Medications
Prescription eye drops to reduce pressure by:
Your physician will review proper drop technique and discuss side effects, interactions, and dosing schedules.
Laser Therapy
Laser procedures can improve drainage or reduce fluid production. Options include:
Surgical Management
If pressure remains too high despite medications and laser therapy, surgery options include:
These procedures help maintain long-term pressure control and protect against further vision loss.
Glaucoma requires lifelong monitoring. Follow-up intervals depend on disease severity but typically include:
Your ophthalmologist at The Medical Group of New Jersey will adjust your treatment plan as needed to ensure optimal and stable vision.